MENU

NSRX Nasus Pharma Ltd. Forecast, Technical & Fundamental Analysis

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions... Show more

NSRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
NSRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NSRX is expected to report earnings to fall 68.42% to -11 cents per share on December 02

Nasus Pharma Ltd. NSRX Stock Earnings Reports
Q3'26
Est.
$-0.12
Q4'25
Beat
by $0.15
The last earnings report on February 25 showed earnings per share of -37 cents, beating the estimate of -52 cents. With 4.21K shares outstanding, the current market capitalization sits at 39.88M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Details
Industry
N/A
Address
Yigal Alon 65
Phone
+972 35736632
Employees
N/A
Web
https://www.nasuspharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TGVIX38.310.12
+0.31%
Thornburg International Equity I
CSIIX9.57N/A
N/A
Copeland International Small Cap I
MNNAX67.03N/A
N/A
Victory Multi-Cap A
PJGQX20.65N/A
N/A
PGIM Jennison Mid-Cap Growth R6
TLASX12.64N/A
N/A
Transamerica Large Core ESG R6

NSRX and Stocks

Correlation & Price change

A.I.dvisor tells us that NSRX and MDCX have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSRX and MDCX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSRX
1D Price
Change %
NSRX100%
+1.64%
MDCX - NSRX
4%
Poorly correlated
+0.74%
OGN - NSRX
-4%
Poorly correlated
+0.07%
ABBV - NSRX
-12%
Poorly correlated
+0.83%
Nasus Pharma (NSRX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com